FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment

FDA Reviewing Data on MDMA , for Potential Approval of , Groundbreaking PTSD Treatment.

'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD).

'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD).

The news comes after decades of psychedelic advocates urging regulators to give the drug medical acceptance.

.

On June 4, the Food and Drug Administration (FDA) called on a group of outside experts to review the latest MDMA research.

.

The research suggests that when the drug is paired with talk therapy, it can help alleviate PTSD.

.

However, regulators at the FDA have questioned the reliability of the data, as well as the potential safety risks, which include possible heart problems and addiction.

FDA approval could open the door for federal approval to be granted as soon as this summer.

.

Approval would make MDMA, often referred to as ecstasy or molly, the first illegal psychedelic to receive approval for mainstream medicine.

.

'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction.

'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction.

It’s clear that MDMA-assisted therapy would be a welcome addition to the currently available options, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'.

I’ve seen firsthand how this treatment can be lifesaving for some, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'